Literature DB >> 8884544

Clinical features and hormonal characteristics in a case of ovarian arrhenoblastoma.

P Tita1, A Spina, G Briguglia, A Magro, D Gallo, C Finocchiaro, G Padova, V Pezzino.   

Abstract

We report a case of a 34-year-old woman affected with ovarian arrhenoblastoma characterized by very high testosterone (T) levels (34.0-60.0 ng/ml; n.v.0.2-0.9) and suppressed gonadotropin levels. The physical examination revealed: severe hirsutism, acne, amenorrhea and other virilization signs. Basal hormonal evaluation also showed a markedly elevated 17-hydroxyprogesterone (17-OHP) and a mild delta 4 Androstenedione (A) and dehydroepiandrosterone sulfate (DHEAs) increase. ACTH test induced only slight changes in androgen secretion. By contrast, dexamethasone test greatly decreased A and DHEAs whereas T levels were only partially suppressed. Moreover, hCG test was clearly stimulatory for T and A. Suppressed gonadotropin levels did not respond to LHRH stimulation. The removal of the neoplasia was followed by normalization of T levels and increase of serum gonadotropins with subsequent restoration of a normal responsiveness to LHRH and resumption of an ovulatory menstrual cycle. This observation suggests that the high T levels played a primary role in the pathogenesis of the gonadotropin suppression and anovulation. Recovery of acne was complete whereas hirsutism score was reduced but still elevated after one year. This may be due to postoperative A and DHEAs levels slightly above the normal range, indicating the presence of adrenal hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8884544     DOI: 10.1007/BF03349895

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin.

Authors:  J R Tucci; W Zäh; A E Kalderon
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

2.  Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome.

Authors:  R A Lobo; U Goebelsmann
Journal:  Am J Obstet Gynecol       Date:  1982-02-15       Impact factor: 8.661

3.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

Authors:  R Rebar; H L Judd; S S Yen; J Rakoff; G Vandenberg; F Naftolin
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

4.  Evidence of a role of adrogens in follicular maturation.

Authors:  J P Louvet; S M Harman; J R Schrieber; G T Ross
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

5.  An attenuated form of congenital virilizing adrenal hyperplasia.

Authors:  Z Rosenwaks; P A Lee; G S Jones; C J Migeon; A C Wentz
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

6.  Gonadotropin receptors in experimentally induced ovarian tumors in mice.

Authors:  S Kammerman; R I Demopoulos; J Ross
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

7.  Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors).

Authors:  M Munemura; S Inoue; R Himeno; N Koyama; J Mizumoto; M Maeyama; T Iwamasa
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

8.  The steroid profile of a virilizing ovarian tumor.

Authors:  M R Soules; G E Abraham; E H Bossen
Journal:  Obstet Gynecol       Date:  1978-07       Impact factor: 7.661

9.  Amenorrhea with cryptic hyperandrogenemia.

Authors:  T J McKenna; A Moore; F Magee; S Cunningham
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

10.  The clitoral index: a bioassay of androgenic stimulation.

Authors:  G E Tagatz; R A Kopher; T C Nagel; T Okagaki
Journal:  Obstet Gynecol       Date:  1979-11       Impact factor: 7.661

View more
  2 in total

1.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Authors:  A Bachelot; K Laborde; J L Bresson; G Plu-Bureau; A Raynaud; X Bertagna; A Mogenet; M Mansour; V Lucas-Jouy; J-P Gayno; Y Reznik; J-M Kuhn; L Billaud; M-C Vacher-Lavenu; M Putterman; I Mowszowicz; P Touraine; F Kuttenn
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

2.  Changing pattern of gonadotropins in a patient with an adrenal-androgen secreting tumor.

Authors:  Jose Antonio Miguel Marcondes; Cristiano R G Barcellos; Michelle P Rocha; Hélio Bisi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.